These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Vasospastic disorders. Etiology, recognition, and treatment. Miller LM; Morgan RF Hand Clin; 1993 Feb; 9(1):171-87. PubMed ID: 8444973 [TBL] [Abstract][Full Text] [Related]
9. [Effectiveness of temperature biofeedback in therapy of Raynaud's disease]. Büttner M; Henschel G; Spengel FA Vasa Suppl; 1991; 32():411-5. PubMed ID: 1771546 [No Abstract] [Full Text] [Related]
10. Induced vasodilation as a home treatment for Raynaud's disease. Jobe JB; Beetham WP; Roberts DE; Silver GR; Larsen RF; Hamlet MP; Sampson JB J Rheumatol; 1985 Oct; 12(5):953-6. PubMed ID: 4087271 [TBL] [Abstract][Full Text] [Related]
15. Biofeedback treatment of Raynaud's disease and phenomenon. Freedman RR; Lynn SJ; Ianni P; Hale PA Biofeedback Self Regul; 1981 Sep; 6(3):355-65. PubMed ID: 7326270 [TBL] [Abstract][Full Text] [Related]
16. Raynaud's Phenomenon: treatment of a severe case with biofeedback. Adair JR; Theobald DE J Indiana State Med Assoc; 1978 Oct; 71(10):990-3. PubMed ID: 701835 [No Abstract] [Full Text] [Related]
17. Efficacy of myofascial release techniques in the treatment of primary Raynaud's phenomenon. Walton A J Bodyw Mov Ther; 2008 Jul; 12(3):274-80. PubMed ID: 19083682 [TBL] [Abstract][Full Text] [Related]
18. Pathophysiology and clinical consequences of Raynaud's phenomenon related to systemic sclerosis. Sunderkötter C; Riemekasten G Rheumatology (Oxford); 2006 Oct; 45 Suppl 3():iii33-5. PubMed ID: 16987831 [TBL] [Abstract][Full Text] [Related]